These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 29614184)

  • 41. Update on the pharmacologic management of neonatal abstinence syndrome.
    Bio LL; Siu A; Poon CY
    J Perinatol; 2011 Nov; 31(11):692-701. PubMed ID: 21869765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacological Treatments for Neonatal Abstinence Syndrome: A Systematic Review and Network Meta-analysis.
    Disher T; Gullickson C; Singh B; Cameron C; Boulos L; Beaubien L; Campbell-Yeo M
    JAMA Pediatr; 2019 Mar; 173(3):234-243. PubMed ID: 30667476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome.
    Lemon LS; Caritis SN; Venkataramanan R; Platt RW; Bodnar LM
    Epidemiology; 2018 Mar; 29(2):261-268. PubMed ID: 29112519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
    Jones HE; Heil SH; Baewert A; Arria AM; Kaltenbach K; Martin PR; Coyle MG; Selby P; Stine SM; Fischer G
    Addiction; 2012 Nov; 107 Suppl 1(0 1):5-27. PubMed ID: 23106923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rooming-in program to mitigate the need to treat for opiate withdrawal in the newborn.
    Hodgson ZG; Abrahams RR
    J Obstet Gynaecol Can; 2012 May; 34(5):475-81. PubMed ID: 22555142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methadone versus morphine treatment outcomes in neonatal abstinence syndrome: A meta-analysis.
    Xiao F; Yan K; Zhou W
    J Paediatr Child Health; 2019 Oct; 55(10):1177-1182. PubMed ID: 31479559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Breastfeeding and rooming-in in the management of neonatal abstinence syndrome. Scoping review].
    Baeza-Gozalo P; Sola-Cía S; López-Dicastillo O
    An Sist Sanit Navar; 2023 Aug; 46(2):. PubMed ID: 37639321
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
    Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
    Paterno MT; Jablonski L; Klepacki A; Friedmann PD
    J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Wide Variation Found in Care of Opioid-Exposed Newborns.
    Bogen DL; Whalen BL; Kair LR; Vining M; King BA
    Acad Pediatr; 2017; 17(4):374-380. PubMed ID: 27889436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
    Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
    J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.
    Gaalema DE; Heil SH; Badger GJ; Metayer JS; Johnston AM
    Drug Alcohol Depend; 2013 Nov; 133(1):266-9. PubMed ID: 23845658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
    Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
    Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
    Brown MS; Hayes MJ; Thornton LM
    J Perinatol; 2015 Apr; 35(4):278-83. PubMed ID: 25357093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Integrated Review of the Assessment of Newborns With Neonatal Abstinence Syndrome.
    Casavant SG; Meegan T; Fleming M; Hussain N; Gork S; Cong X
    J Obstet Gynecol Neonatal Nurs; 2021 Sep; 50(5):539-548. PubMed ID: 34116058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.
    Schiff DM; Wachman EM; Philipp B; Joseph K; Shrestha H; Taveras EM; Parker MGK
    Breastfeed Med; 2018 May; 13(4):266-274. PubMed ID: 29630387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.